BioCentury
ARTICLE | Clinical News

Dopascan: Phase III testing update

April 5, 1999 7:00 AM UTC

Guilford Pharmaceuticals Inc. (GLFD), Baltimore, Md. Product: Dopascan Business: Neurological Therapeutic category: Test Target: Dopamine transporter Description: Iodinated tropane derivative dopamine...